跳至主要内容
临床试验/CTRI/2024/12/077965
CTRI/2024/12/077965尚未招募2/3 期

RANDOMIZED UNCONTROL CLINICAL TRIAL OF EFFICACY OF TAB KANCHANAR IN RAKTAPRADAR (MENORRHAGIA) DUE TO FIBROID.

Dr Kanchan Madhav Rote1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2024年12月30日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
54
试验地点
1
主要终点
To evaluate the efficacy of Tab Kanchanar in Raktapradar.

研究概览

简要总结

In ayurveda the term asrugdara called pradiran which means excessive menstrual blood loss and prolonged menstrual bleeding. It is not directly mentioned as disease but given as symptom of gynaecological disorder. Asrugdara is also known as Raktapradar as mentioned in Charak samhita.

In modern science Raktapradar can be correlated with menorrhagia. Menorrhagia is defined as a cyclic menstrual bleeding at normal intervals which is excessive bleeding means > 80ml or prolonged menstruation means >7 days or both.

Any uterine bleeding outside the normal volume, duration, regularity or frequency is considered as Abnormal uterine bleeding.

Nowadays various treatment modalities like hormonal therapy, antiprostaglandins, antifibrinolytic agents are available to treat menorrhagia. But hormonal therapy has many side effects and once you stop the treatment relapse is there after sometime. There is no definite treatment available for uterine fibroids in modern science. As mentioned in samhitas, Raktapradar is type of adhog raktapitta in which pitta and vata dosha, rasa and rakta dhatu vikruti found as heavy blood loss which is an emergency need to treat as early as possible. So raktasthambhan chikitsa is to be done to stop the blood loss. Rakta Kanchanar is kashay, sheet, sangrahi, raktapittaghna hence is selected for this study.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • 1.Patient willing to give informed written consent.
  • 2.Patient having heavy menstrual bleeding with duration of bleeding more than 7 days or amount of bleeding more than 80ml or both at least 2 consecutive cycles.

排除标准

  • Patient having fibroid size more than 4cm.
  • Post menopausal bleeding.
  • Hb less than 7g/dL.
  • Patient using IUCD.
  • Pregnant women.
  • Patient having congenital anomalies.

结局指标

主要结局

To evaluate the efficacy of Tab Kanchanar in Raktapradar.

时间窗: 90 Days

次要结局

  • To review Ayurvedic Concept of Raraktapradar according to(different Acharyas.)

研究者

发起方
Dr Kanchan Madhav Rote
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Kanchan Madhav Rote

Hon Shri Annasaheb Dange Ayurved Medica College Post Graduate and Research Center Ashta

研究点 (1)

Loading locations...

相似试验

A Clinical Trial To Study The Effect Of Oral... | 临床试验